Laser vaginal rejuvenation
MonaLisa Touch · CO₂ and erbium intimate lasers · the FDA warning
'Vaginal rejuvenation' is a growth category in aesthetic clinics worldwide, searched by menopausal women, breast cancer survivors who cannot use oestrogen, and younger women sold 'tightening' after childbirth.
Search interest: about 200 searches a month in Singapore for “vaginal rejuvenation” (Ahrefs, October 2026).
The FDA warning was about the marketing, and the marketing has not improved much.
Reviewed against the Aesthetics International standard. Category: Procedures.
Does Laser vaginal rejuvenation work?
Promising. The FDA warning was about the marketing, and the marketing has not improved much. For genitourinary syndrome of menopause the data are reasonable: a 2021 meta-analysis of three sham-controlled trials favoured CO₂ laser for dryness and sexual function scores, and a 2022 JAMA Network Open meta-analysis of six trials found laser similar to vaginal oestrogen.
- Verdict
- Promising Plausible mechanism and early evidence. Reasonable to try with realistic expectations.
- Evidence base
- 4 PubMed-indexed studies cited below, including systematic reviews, randomised trials.
- Suits
- Postmenopausal women and cancer survivors with dryness, irritation or painful sex who cannot or will not use vaginal oestrogen, after gynaecological assessment.
- Not for
- 'Tightening' for its own sake, stress incontinence as a first-line treatment, prolapse, active infection, undiagnosed bleeding. It will not change sensation or orgasm.
- In Singapore
- CO₂ and erbium intimate lasers are HSA-registered devices used by gynaecologists and doctors in Singapore.
- Category
- Procedures · about 200 searches a month in Singapore for “vaginal rejuvenation”
- Reviewed
- 1 October 2026 by Aesthetics International. Revised as evidence and regulation change.
What it is
Fractional CO₂ or erbium laser energy delivered through a probe to the vaginal wall, and sometimes the vulva, to stimulate the thinned, dry mucosa of the genitourinary syndrome of menopause. The same devices are marketed for laxity, stress incontinence and sexual function, which is where the evidence thins and the regulators object.
How it works
Microscopic thermal columns in the epithelium and lamina propria trigger remodelling, new collagen and better glycogen-rich epithelium, so the tissue becomes thicker, more elastic and better lubricated over a course of three sessions. Whether a laser can tighten the vaginal canal in a meaningful, lasting way, or support the urethra enough to stop leakage, is a different question with a different answer. Candidate selection and a gynaecological examination decide the result.
What the evidence says
For genitourinary syndrome of menopause the data are reasonable: a 2021 meta-analysis of three sham-controlled trials favoured CO₂ laser for dryness and sexual function scores, and a 2022 JAMA Network Open meta-analysis of six trials found laser similar to vaginal oestrogen. But a well-designed 2023 sham-controlled trial in breast cancer survivors, LIGHT, found no difference between laser and sham at six months, which is a warning about placebo response. For stress incontinence erbium laser results are contradictory: one 2024 multicentre sham-controlled trial was positive and a 2025 double-blind trial found no difference from sham. In 2018 the US FDA warned that no energy device was cleared for 'rejuvenation', tightening or sexual function and that burns, scarring and pain had been reported.
What people are saying
Paraphrased from public discussion on TikTok, Instagram, Reddit and in the press. Not testimonials, and not about any one clinic. Reported in: nbcnews.com, medsafe.govt.nz, augs.org.
What the studies show
- systematic review
Three sham-controlled trials of 164 women favoured CO₂ laser for vaginal symptom, sexual function and urinary distress scores, with a call for larger trials.
Vaginal CO2 laser therapy versus sham for genitourinary syndrome of menopause management: a systematic review and meta-analysis of randomized controlled trials. — Menopause, 2021. PMID 34374686.
- systematic review
Six randomised trials of 270 women found no significant difference between CO₂ laser and vaginal oestrogen in genitourinary symptom scores.
Comparison of Severity of Genitourinary Syndrome of Menopause Symptoms After Carbon Dioxide Laser vs Vaginal Estrogen Therapy: A Systematic Review and Meta-analysis. — JAMA Netw Open, 2022. PMID 36129710.
- RCT
In 72 breast cancer survivors both laser and sham groups improved at six months, with no significant difference between them.
Effect of Fractional Carbon Dioxide vs Sham Laser on Sexual Function in Survivors of Breast Cancer Receiving Aromatase Inhibitors for Genitourinary Syndrome of Menopause: The LIGHT Randomized Clinical Trial. — JAMA Netw Open, 2023. PMID 36763359.
- RCT
In 144 women erbium vaginal laser was no more effective than sham for curing or improving stress incontinence at six months.
Double-blind randomized controlled trial of Er: YAG vaginal laser to treat female stress urinary incontinence. — Am J Obstet Gynecol, 2025. PMID 39603442.
Studies are selected for relevance and quality, not for agreement with the verdict; PubMed records are linked so the reader can check them.
Who it suits
Suits
Postmenopausal women and cancer survivors with dryness, irritation or painful sex who cannot or will not use vaginal oestrogen, after gynaecological assessment.
Not for
'Tightening' for its own sake, stress incontinence as a first-line treatment, prolapse, active infection, undiagnosed bleeding. It will not change sensation or orgasm.
Alternatives
The two reviewed treatments most often weighed against Laser vaginal rejuvenation, on the same standard.
| Laser vaginal rejuvenation | Milia removal | Skin tag removal | |
|---|---|---|---|
| Verdict | Promising | Established | Established |
| What it is | Fractional CO₂ or erbium laser energy delivered through a probe to the vaginal wall, and sometimes the vulva, to stimulate the thinned, dry mucosa of the genitourinary syndrome of menopause. | Milia are tiny keratin-filled cysts just beneath the skin surface, one to two millimetres across, white or yellowish, typically around the eyes and cheeks. | Skin tags are soft, benign, skin-coloured or slightly darker growths on a narrow stalk, from a millimetre to a centimetre, in the folds — neck, armpits, groin, eyelids. |
| Evidence base | 4 PubMed-indexed studies cited below, including systematic reviews, randomised trials. | 2 PubMed-indexed studies cited below (review, technique note); no systematic review or randomised trial on the claim itself. | 2 PubMed-indexed studies cited below (observational study, review); no systematic review or randomised trial on the claim itself. |
| Suits | Postmenopausal women and cancer survivors with dryness, irritation or painful sex who cannot or will not use vaginal oestrogen, after gynaecological assessment. | Primary milia around the eyes and cheeks in adults, secondary milia after a procedure, and anyone who wants them gone in one visit rather than hoping skincare will work. | Tags that catch, rub or bleed, or that the person simply wants gone, removed by a doctor in a single visit; people with many tags who also want a metabolic check. |
| In one line | The FDA warning was about the marketing, and the marketing has not improved much. | The error is spending months on products that cannot reach a cyst under intact skin. | The only judgement needed is confirming it is a tag; after that, it is scissors and a minute. |
Risks
Transient discharge, spotting and discomfort; reports to the FDA include burns, scarring and persistent pain, mostly from aggressive settings or poor selection.
In Singapore
CO₂ and erbium intimate lasers are HSA-registered devices used by gynaecologists and doctors in Singapore. Dr Sin Yong's G Lift is a CO₂ intimate wellness protocol built on the genitourinary-health evidence, not on tightening claims; this is an editorial review, not an offer.
“The FDA warning was about the marketing, and the marketing has not improved much.”
Vetted protocols on the same problem
Questions
Does the laser tighten the vagina?
Is it safe after breast cancer?
How many sessions?
Cite this review
Aesthetics International (2026). Laser vaginal rejuvenation: does it work? Evidence, risks and verdict. https://aesthetics-international.org/treatments/laser-vaginal-rejuvenation/ (reviewed 1 October 2026).
Editorial, unpaid and independent of any manufacturer. Verdict: Promising. See what works and what doesn't across all 153 reviews. Spotted an error or a newer study? Suggest a correction — changes are logged on the corrections page. Terms are defined in the glossary.
Have a question about this treatment?
Ask us — or ask to be matched with a practitioner in Singapore who follows evidence-based treatment. Whether it is right for you is decided at an in-person assessment, not by a review; sometimes the answer is a different treatment, or none.
WhatsApp +65 8023 7170Suggest a treatment to review
Physicians, manufacturers and readers can propose a treatment for review. Reviews are editorial and are not paid for.
[email protected]